Publication:

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design (2009)

Author(s): van Schie RMF, Wadelius M, Kamali F, Daly AK, Manolopoulos VG, de Boer A, Barallon R, Verhoef TI, Kirchheiner J, Haschke-Becher E, Briz M, Rosendaal FR, Redekop WK, Pirmohamed M, Maitland-van eer Zee AH

      • Date: 01-10-2009
      • Journal: Pharmacogenomics
      • Volume: 10
      • Issue: 10
      • Pages: 1687-1695
      • Publisher: Future Medicine Ltd.
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: acenocoumarol CYP2C9 dosing algorithm EU-PACT pharmacogenetics phenprocoumon randomized controlled trial VKORC1 warfarin EPOXIDE REDUCTASE COMPLEX CYTOCHROME P4502C9 ORAL ANTICOAGULATION HYBEACON(TM) PROBES ATRIAL-FIBRILLATION CYP2C9 GENOTYPES CLINICAL FACTORS BLEEDING RISK VKORC1 GENE WARFARIN

      Staff

      Professor Ann Daly
      Professor of Pharmacogenetics